Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/two-cuhk-research-projects-receive-state-science-and-technology-awards
https://www.med.cuhk.edu.hk/press-releases/two-cuhk-research-projects-receive-state-science-and-technology-awards

Two CUHK Research Projects Receive State Science and Technology Awards

The 2017 State Science and Technology Awards ceremony was held at the Great Hall of the People in Beijing recently. Two collaborative research projects participated in by The Chinese University of Hong Kong (CUHK), namely ‘Development and Promotion of Molecular Targeted Therapy for Lung Cancer Patients’, and ‘Innovative Strategy and Technology for the Prevention and Treatment of Stroke’, each received a State Scientific and Technological Progress Award (second-class). 

 

Development and Promotion of Molecular Targeted Therapy for Lung Cancer Patients

Prof. Tony Shu Kam MOK, Li Shu Fan Medical Foundation Professor of Clinical Oncology and Chairman of the Department of Clinical Oncology at the Faculty of Medicine at CUHK, has been collaborating with Prof. Yi-Long WU and his team from Guangdong General Hospital at the Guangdong Academy of Medical Sciences in lung cancer researches since 1999, especially focusing on epidermal growth factor receptor (EGFR) mutation happening in patients with lung adenocarcinoma.

 

Over the years, they achieved a number of breakthroughs which include: inventing molecular mutation targeted therapy for lung cancer patients which helps extend the survival period from 10 months to 22 months, thus setting a new treatment model; realising that EGFR mutation will make cancer cells ‘evolve’ and create a new driver oncogene in patients, hence developing resistance to first-line targeted therapy; finding that, for patients whose cancer genes further mutate and develop resistance after first-line EGFR targeted therapy, a new treatment can double the progression-free survival when compared with standard chemotherapy.

 

With the success of these trials and developments, the team has helped define ‘personalised medicine’ for lung cancer in mainland China and the world. Their studies were used for the registration of multiple targeted drugs in mainland China, allowing thousands of patients to receive first-line EGFR targeted therapy drugs at low cost. All the mentioned studies have been published in world renowned journals including The New England Journal of Medicineand The Lancet Oncology.

 

Professor Mok remarked, ‘I have been closely working with Prof Yi-Long WU for nearly 20 years and made multiple breakthroughs in the treatment of lung cancers, finding new treatment paradigms of mutated lung cancers which have set new international guidelines and standards. The most valuable output from this long term collaboration with mainland China is not the National Award, but the great friendship we have built by helping and respecting each other. Our ultimate goal is to make advanced lung cancer no longer fatal, but a chronic disease which could be treated with drugs.’

 

The two professors have also founded the Lung Cancer Research Group in Asia and the Chinese Thoracic Oncology Group on the mainland, and are working on the development of biomarkers for detection of oncogene.

 

Innovative Strategy and Technology for the Prevention and Treatment of Stroke

Prof. Lawrence Ka Sing WONG, Clinical Professor (honorary) of the Department of Medicine and Therapeutics at the Faculty of Medicine at CUHK, in collaboration with the Third Military Medical University and Chongqing Medical University, has been working on the prevention and treatment of stroke for many years. His team works on the epidemiology, pathogenesis and treatment of intracranial atherosclerosis.

 

Ischemic stroke is one of the leading causes of adult disability in China, with a high risk of subsequent recurrence. Professor Wong first confirmed that intracranial atherosclerosis, which means narrowing of blood vessels in the brain, is the predominant stroke subtype in Chinese patients with stroke, based on his study at the Prince of Wales Hospital. His team’s study using microembolic signal monitoring has also established that dual antiplatelet therapy is more effective than aspirin alone in reducing microembolism in patients with Transient Ischemic Attack (TIA) and minor stroke. Based on the results of this study, subseqƒ©uent studies have confirmed that dual antiplatelet is the best medical therapy for minor stroke.

 

Recently, Professor Wong and his team have moved on to investigate new treatments to improve the motor function of disabled patients after stroke. His team observed that external counterpulsation is able to enhance blood flow to the brain and might improve functional recovery after stroke. Transcranial magnetic stimulation is another innovative approach to help the recovery of motor function by rewiring the damaged pathway linking the brain to the body.

 

Professor Wong is very encouraged by the award. He is also confident that the development of stroke therapy will continue to improve through researches. He said, ‘It is noteworthy that there may be synergistic effects from combining both treatments; with one augmenting the blood flow to the brain and the other revitalising the circuit between the limbs and the brain. These new innovative treatments may offer hope to stroke patients who remain disabled even after the best medical and physical therapy.’

 

Prof. Tony MOK, Li Shu Fan Medical Foundation Professor of Clinical Oncology and Chairman of the Department of Clinical Oncology at the Faculty of Medicine at CUHK (fourth from right), collaborated with Prof. Yi-Long WU (centre) and his team from Guangdong General Hospital at the Guangdong Academy of Medical Sciences in lung cancer researches. Their project entitled ‘Development and Promotion of Molecular Targeted Therapy for Lung Cancer Patients’ has been honoured with the State Scientific and Technological Progress Award second-class award.

Prof. Tony MOK, Li Shu Fan Medical Foundation Professor of Clinical Oncology and Chairman of the Department of Clinical Oncology at the Faculty of Medicine at CUHK (fourth from right), collaborated with Prof. Yi-Long WU (centre) and his team from Guangdong General Hospital at the Guangdong Academy of Medical Sciences in lung cancer researches. Their project entitled ‘Development and Promotion of Molecular Targeted Therapy for Lung Cancer Patients’ has been honoured with the State Scientific and Technological Progress Award second-class award.

Prof. Tony MOK

Prof. Tony MOK

Prof. Lawrence WONG, Clinical Professor (honorary) of the Department of Medicine and Therapeutics at the Faculty of Medicine at CUHK, is very encouraged about the recipient of the State Scientific and Technological Progress Award second-class award. He is also confident that the development of stroke therapy will continue to improve through researches.

Prof. Lawrence WONG, Clinical Professor (honorary) of the Department of Medicine and Therapeutics at the Faculty of Medicine at CUHK, is very encouraged about the recipient of the State Scientific and Technological Progress Award second-class award. He is also confident that the development of stroke therapy will continue to improve through researches.

More Press Releases

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

Awards and honors
CU Medicine Professor Ronald Ma Receives Prestigious Research Award from  The Asian Association for The Study of Diabetes

CU Medicine Professor Ronald Ma Receives Prestigious Research Award from The Asian Association for The Study of Diabetes

Awards and honors
Professor Tony Mok Recognised as a Giant of Cancer Care  for His Remarkable Contribution in Advancing Global Healthcare in Lung Cancer

Professor Tony Mok Recognised as a Giant of Cancer Care for His Remarkable Contribution in Advancing Global Healthcare in Lung Cancer

Awards and honors
CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

Awards and honors
CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Awards and honors
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
Clarification -- 聲稱為莫樹錦教授署名文章証實為假冒 (Chinese Version Only)

Clarification -- 聲稱為莫樹錦教授署名文章証實為假冒 (Chinese Version Only)

Response
CUHK Medicine Professor Juliana Chan Receives International Honour for  Outstanding Research and Care in Diabetes

CUHK Medicine Professor Juliana Chan Receives International Honour for Outstanding Research and Care in Diabetes

Awards and honors
Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Awards and honors
CUHK Receives an International Cancer Care Team Award Nominated by Patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

Awards and honors
Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Awards and honors
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Awards and honors
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

Awards and honors
CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

CUHK Leads a Multinational Study that Finds New Treatment Paradigm of Mutated Lung Cancer

Research
CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

Awards and honors
CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

Awards and honors
CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

CUHK Jointly Discovers New Therapeutic Solution for Minor Stroke in Global Study with over 30 Countries

Research
CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

CUHK Sees Early Evaluation of TIA Patients Reduce Rate of Stroke by 70% in a Global Study of 21 Countries

Research
CUHK Professor Hui Yao LAN’s Research on Chronic Kidney Disease Wins First Prize in Chinese Medical Science and Technology Award

CUHK Professor Hui Yao LAN’s Research on Chronic Kidney Disease Wins First Prize in Chinese Medical Science and Technology Award

Awards and honors
CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

CUHK Screening Reveals 1 in 3 Older Adults in Community Suffer Brain Small Vessel Disease, Early Prevention Recommended

Clinical service
CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

Awards and honors
CUHK Professor Diana Lee Inducted as Fellow of American Academy of Nursing

CUHK Professor Diana Lee Inducted as Fellow of American Academy of Nursing

Awards and honors
CUHK Medical Student Wins Grand Prize in FameLab Contest Hong Kong to Compete in FameLab International in UK

CUHK Medical Student Wins Grand Prize in FameLab Contest Hong Kong to Compete in FameLab International in UK

Awards and honors
CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

Awards and honors
CUHK Announces Latest Medical Treatment for Minor Stroke

CUHK Announces Latest Medical Treatment for Minor Stroke

Research
CUHK Received Four Ministry of Education Higher Education Outstanding Scientific Research Output Awards The Highest Share among Hong Kong Institutions

CUHK Received Four Ministry of Education Higher Education Outstanding Scientific Research Output Awards The Highest Share among Hong Kong Institutions

Awards and honors

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.